erythromycin has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahvar, N; Atashbar, S; Mersa, A; Salimi, A | 1 |
| Agladze, KI; Dementyeva, EV; Podgurskaya, AD; Slotvitsky, MM; Tsvelaya, VA; Valetdinova, KR | 1 |
2 other study(ies) available for erythromycin and Cardiotoxicity
| Article | Year |
|---|---|
1,25-dihydroxyvitamin D3 prevents deleterious effects of erythromycin on mitochondrial function in rat heart isolated mitochondria.
Topics: Animals; Antioxidants; Calcitriol; Cardiotoxicity; Erythromycin; Heart Diseases; Lipid Peroxidation; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Swelling; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species | 2020 |
The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing.
Topics: Action Potentials; Animals; Animals, Newborn; Anti-Bacterial Agents; Cardiotoxicity; Cell Line; Erythromycin; Heart Rate; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Risk Assessment; Time Factors; Torsades de Pointes; Toxicity Tests; Voltage-Sensitive Dye Imaging | 2019 |